Oxymorphone Hydrochloride 13107-0103
Product NDC
13107-0103- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 26, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA204459
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oxymorphone Hydrochloride | 5 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(3)
100 TABLET in 1 BOTTLE (13107-103-01)
30 TABLET in 1 BOTTLE (13107-103-30)
1000 TABLET in 1 BOTTLE (13107-103-99)